Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Seed Fund (OSF) is a student-led seed fund and an initiative of Said Business School’s Entrepreneurship Centre. Of the hundreds of start-up applications the team reviewed, OSF is excited to announce one of this year’s start-up investments is Hutano Diagnostics.

A glass globe and a calculator sitting on top of investment papers.

2020 has brought unprecedented challenges for communities around the world, and the Oxford Seed Fund (OSF) recognises the heightened importance of entrepreneurship in overcoming them.  Each year the fund provides capital to the University of Oxford’s most promising start-ups as well as being an educational opportunity for students in running an early stage fund from sourcing through to the investment decision. Of the hundreds of start-up applications the team reviewed, OSF is excited to announce this year’s start-up investments are Hutano Diagnostics and DocuVision, Inc. 

 

‘Both companies are doing important work in the global health and AI space respectively,’ comments OSF Managing Director, Tom McQuillen, ‘we are thrilled to support these two start-ups during this pivotal point in their growth journey.’

 

The OSF team spent time getting to know Atherton Mutombwera, Founder of Hutano, and Rama Veeraragoo, Founder of DocuVision, Inc., in order to better understand  their plans and visions for their companies. 

 

Hutano Diagnostics is developing novel chemistry that allows small molecules to be used on Lateral Flow Devices to diagnose diseases such as Ebola and COVID-19. ‘Now, more than ever, we see the need for reliable, consistent, self-administered rapid-diagnostic testing,’ added McQuillen, ‘and we think that Hutano’s platform will be critical in detecting, treating and containing threats such as Covid-19 and Ebola. OSF is excited to be on the journey with Hutano and can’t wait to roll-up our sleeves and help out.’...

 

‘Congratulations to Hutano and DocuVision for reaching key milestones in their start-up journey,’ stated Tom McQuillen. ‘This year’s investment decision was not an easy one for the OSF directors, as there were many applications from other thriving startups like OxRegen Ltd., Crowdless, and Mitra Bio, all of which OSF has confidence in their success.  OSF looks forward to seeing Docuvision and Hutano join the ranks of some of our fastest growing portfolio companies like Onfido, and Go1. Onfido, the AI-based ID verification platform, raised $100M led by TPG Growth earlier this year. Similarly, Go1, an enterprise learning platform, raised a $40M round in May of this year from investors such as Microsoft and Salesforce.’

 

Full press release